Galapagos NV
GLPG
#4563
Rank
NZ$3.65 B
Marketcap
NZ$54.68
Share price
-0.57%
Change (1 day)
19.35%
Change (1 year)

Galapagos NV (GLPG) Fails to deliver data

Key failure to deliver metrics for Galapagos NV:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Galapagos NV (GLPG) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Galapagos NV (GLPG) - since 2013

Volume in USD (price x number of shares), data since 2013

Galapagos NV (GLPG) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025NZ$12.72 M38.05%
2024NZ$9.21 M-73.25%
2023NZ$34.46 M37.16%
2022NZ$25.12 M-77.35%
2021NZ$0.11 B-22.81%
2020NZ$0.14 B75.04%
2019NZ$82.12 M83.74%
2018NZ$44.69 M65.13%
2017NZ$27.06 M34.62%
2016NZ$20.1 M-43.12%
2015NZ$35.35 M3933.77%
2014NZ$0.87 M1389.9%
2013NZ$0.05 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
AstraZeneca
AZN
NZ$21.14 MNZ$0.11 B๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
NZ$54.31 MNZ$94.31 M๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$4.1 MNZ$62.72 M๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
NZ$21.44 MNZ$0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
NZ$3.48 MNZ$9.7 M๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$72.42 MNZ$0.44 B๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$1.84 MNZ$36.3 M๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
NZ$72.01 MNZ$0.40 B๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
NZ$33.81 MNZ$0.17 B๐Ÿ‡บ๐Ÿ‡ธ USA